These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. Steptoe RJ; Ritchie JM; Harrison LC J Immunol; 2002 May; 168(10):5032-41. PubMed ID: 11994455 [TBL] [Abstract][Full Text] [Related]
24. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Zorina TD; Subbotin VM; Bertera S; Alexander AM; Haluszczak C; Gambrell B; Bottino R; Styche AJ; Trucco M Stem Cells; 2003; 21(4):377-88. PubMed ID: 12832692 [TBL] [Abstract][Full Text] [Related]
25. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes. Li R; Perez N; Karumuthil-Melethil S; Vasu C Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402 [TBL] [Abstract][Full Text] [Related]
27. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice. Kimura T; Ito A; Hancock WW; Maki T J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295 [TBL] [Abstract][Full Text] [Related]
28. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Ikehara S; Kawamura M; Takao F; Inaba M; Yasumizu R; Than S; Hisha H; Sugiura K; Koide Y; Yoshida TO Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8341-4. PubMed ID: 2236044 [TBL] [Abstract][Full Text] [Related]
29. Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice. Hanafusa T; Sugihara S; Fujino-Kurihara H; Miyagawa J; Miyazaki A; Yoshioka T; Yamada K; Nakajima H; Asakawa H; Kono N Diabetes; 1988 Feb; 37(2):204-8. PubMed ID: 3292315 [TBL] [Abstract][Full Text] [Related]
30. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008 [TBL] [Abstract][Full Text] [Related]
33. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883 [TBL] [Abstract][Full Text] [Related]
34. A single recessive non-MHC diabetogenic gene determines the development of insulitis in the presence of an MHC-linked diabetogenic gene in NOD mice. Hattori M; Fukuda M; Ichikawa T; Baumgartl HJ; Katoh H; Makino S J Autoimmun; 1990 Feb; 3(1):1-10. PubMed ID: 2184821 [TBL] [Abstract][Full Text] [Related]
35. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727 [TBL] [Abstract][Full Text] [Related]
36. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Maki T; Ichikawa T; Blanco R; Porter J Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635 [TBL] [Abstract][Full Text] [Related]
37. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. Serreze DV; Gaskins HR; Leiter EH J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229 [TBL] [Abstract][Full Text] [Related]
38. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. Larger E; Bécourt C; Bach JF; Boitard C J Exp Med; 1995 May; 181(5):1635-42. PubMed ID: 7722443 [TBL] [Abstract][Full Text] [Related]
39. Nonobese diabetic natural killer cells: a barrier to allogeneic chimerism that can be reduced by rapamycin. Al-Adra DP; Chan WF; Anderson CC Transplantation; 2011 Nov; 92(9):977-84. PubMed ID: 21956197 [TBL] [Abstract][Full Text] [Related]
40. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse. Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]